Member Info for alfista

Raw material cost doesn't bear comparison at all. Cocoa beans are expensive, and not in good supply. The dietary supplement market is crammed with products, why does anyone imagine that one more will make that much difference? Mock angst on the other channel, as usual.

Reasonable volume, but a good rise today.

My comments here, and on any other board, are just the opinions of one person. Absolutely none have been defamatory, I had a bearish view of Worthington based on my own analysis, and now it is in liquidation, So.....

You have read a little of the science, and then applied a lot of generalities. Patents are not granted lightly are they.

No, I'm using the facts published in the patents, and the EFSA documents, and the GRAS. Whereas you are using non specific generalities.

Indeed, daily consumption of about half a bucket of fresh tomato would achieve a similar result. Garlic, no, nor any of the other suggestions. So, to get smoother platelets, reducing the risk of coronary blockages or DVT, make your greengrocer happy, and get munching away day in, day out.

No, we have talked amongst ourselves about the imminent placing, all understood. Primary purpose is to expand the sales channels for Fruitflow Plus in the UK. The new product launches are referred to in the last RNS, in China, to a target market several times bigger than the whole UK. My opinion is that there is also some demand for shares from that area too, but only time will tell. The collaboration agreement news last year would have had a predictable effect on the share price. Those guys would be well aware what a tie up with a giant retailer in China would have, and they were right. Will they want a larger slice of the holder of the IP in future? I don't know.

If you say so, and after all, you are the expert in being underwater in a share aren't you. I only post official facts, verifiable by reading the RNS function, mighty useful for anyone who want to ignore what any poster on a chat board claims. I don't ask anyone to buy, totally up to them, and, as I've said before, I don't consider that anything written here will affect much at all. We saw a 400% rise on the tie up with Chinese retail giant By Health so I'm not complaining. Yes it has given back some of that gain, but the more substantial product news is all in front of us. So, quite ontent thanks, it will take it's course. Onion, surprised you don't use Fruitflow, it really does work.

You show a complete ignorance of the dietary supplement industry, let alone the specific science regarding Fruitflow. You also say it is small scale, again ignoring successive RNS messages regarding the scaling up to industrial production and worldwide distribution by our Alliance partner Let's be honest Squid, After regarding anyone who contested the lost cause that was Worthington as a troll, you then ironically become a troll, believing that your random rambling will be read by investors and taken seriously. As such, I welcome the chance to put you straight using only official information. Anyone who bought or sold shares without studying the published information, and followed such idiocy as you write, would deserve what they got.

Read the science, because what you write ignores a simple fact

Take a little time to study the science behind the product, because your claim just doesn't stack up. You wrote "oh they would say that", a clear implication that they were just using advertising speak. So you were telling lies. Ooops, I said it again.

There is scientific proof, accepted by regulatory bodies. You should not extend trolling to actually telling lies. That is actionable.

That's quite serious. Are you trying to state that Fruitflow has no proven health benefit?

Hopefully you'll tire of revenge posting, but I doubt it. The prospect doesn't depend on the UK much at all. If you had studied the Alliance Agreement you wouldn't make such daft claims. "Turning to China" is as silly an idea as I've ever read on this board, and I have read a lot. China is a huge market, By Health, with the support of Provexis and DSM, are about to launch more products in to a populace who are more receptive to health supplements than Europe. This giant retail chain are investing in the health benefit of Fruitflow. So, the prospect is of rising revenue flow, from many, many brands using Fruitflow across most of the world. Recurring revenues do not impact on NAV. Even a wordy simpleton must appreciate that.

I recall some figures being posted about the scale of Omega3 consumption a while back. Wouldn't want to guess the actual figure, but I'm certain that the worldwide sales are very impressive. In a way, the article has a point, the public take all health issues too lightly. Food with additives can fail to sell, for a variety of reasons. That is why the emphasis has not been on Fruitflow as an additive, rather as a dietary supplement. Combining it with O3 is a sensible way of using that existing consumption as a way to introduce Fruitflow to folks who obviously appreciate the need to maintain heart health. Has it all taken too long? By Health don't think so, they are putting resources in to developing products for the huge China market. Not too long (H2 2017) to see what they are putting on the shelves of their stores.

Could well be.

Madrid was in 2010 wasn't it? So there more years before you can award the Mystic Missus accolade? I think perhaps signs of market penetration for By Health and Qin drink may move things before then, but if it takes another three then it does. I'd hope that recurring revenues from Fruitflow + Omega3 will be much higher by then, perhaps aided by overseas sales? A business model similar the SiS maybe.

Fact is that the value of Provexis is very unlikely to be influenced by any rant from a reality denial expert from another chat board. The value of Fruitflow IP will be enhanced as more brands containing it become available worldwide, particularly in China as outlined in the RNS. The support of brand launched could well impact on revenues for quite a while yet, as the cost of that support could be deducted before Provexis receive their share. All a lot more long term than anyone portrayed at the start. Quite obvious that notifying a funding requirement so very far ahead would impact the sp. Hopefully this month will get that out of the way, with newsflow from China being the potential for market attention later in the year.

You don't have any to sell. When Gary wrote that, the sp was double after a massive rise. So he had a point. The recent RNS, about the MOU with Chinese retail giant By Health, is an indicator of the future, rather than the past referred to.

Who would HAVE thought that, 10 years on, you would still be incapable of accepting that "would of" is not English. In fact, if all people who could benefit from smoother bloodflow are counted, the target market would exceed 1 billion by a long way. The development continues, as does the education about Fruitflow.